Cardiac magnetic resonance stress testing: Results and prognosis

Current Cardiology Reports

Volumn 11, Issue 1, 2009, Pages 54-60

  Chiribiri, Amedeo ^a   Bettencourt, Nuno ^a   Nagel, Eike ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; EXERCISE TEST; HEART SCINTISCANNING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION AND FORECASTING; REPRODUCIBILITY; REVIEW;

CARDIOVASCULAR DISEASES; EXERCISE TEST; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 63249109110     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-009-0009-9     Document Type: Article

References (34)

1. Nandalur KR, Dwamena BA, Choudhri AF, et al.: Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 2007, 50:1343-1353. Meta-analysis comparing the results of cardiac stress MR with coronary angiography. (Pubitemid 47449733)
2. Hendel RC, Patel MR, Kramer CM, et al.: ACCF/ACR/SCCT/SCMR/ASNC/NASCI/ SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006, 48:1475-1497. Appropriateness criteria statement for CT and MR.
3. Ishida N, Sakuma H, Motoyasu M, et al.: Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 2003, 229:209-216. (Pubitemid 37152126)
4. Pilz G, Bernhardt P, Klos M, et al.: Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography. Clin Res Cardiol 2006, 95:531-538. (Pubitemid 44496717)
5. Takase B, Nagata M, Kihara T, et al.: Whole-heart dipyridamole stress first-pass myocardial perfusion MRI for the detection of coronary artery disease. Jpn Heart J 2004, 45:475-486. (Pubitemid 41518890)
6. Doyle M, Fuisz A, Kortright E, et al.: The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study. J Cardiovasc Magn Reson 2003, 5:475-485. (Pubitemid 36859430)
7. Nagel E, Klein C, Paetsch I, et al.: Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003, 108:432-437. (Pubitemid 36935536)
8. Plein S, Greenwood JP, Ridgway JP, et al.: Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004, 44:2173-2181. (Pubitemid 39576037)
9. Plein S, Radjenovic A, Ridgway JP, et al.: Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology 2005, 235:423-430. (Pubitemid 40571077)
10. Wolff SD, Schwitter J, Coulden R, et al.: Myocardial firstpass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation 2004, 110:732-737. (Pubitemid 39056274)
11. Giang TH, Nanz D, Coulden R, et al.: Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 2004, 25:1657-1665. (Pubitemid 39209287)
12. Schwitter J, Wacker CM, van Rossum AC, et al.: MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008, 29:480-489. Recent multicenter, multivendor, randomized trial comparing MR perfusion with SPECT. (Pubitemid 351264187)
13. Pennell DJ, Underwood SR, Ell PJ, et al.: Dipyridamole magnetic resonance imaging: a comparison with thallium-201 emission tomography. Br Heart J 1990, 64:362-369.
14. Pennell DJ, Underwood SR, Manzara CC, et al.: Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992, 70:34-40.
15. Baer FM, Smolarz K, Jungehülsing M, et al.: Feasibility of high-dose dipyridamole-magnetic resonance imaging for detection of coronary artery disease and comparison with coronary angiography. Am J Cardiol 1992, 69:51-56.
16. van Rugge FP, van der Wall EE, de Roos A, Bruschke AV: Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am Coll Cardiol 1993, 22:431-439. (Pubitemid 23214555)
17. van Rugge FP, van der Wall EE, Spanjersberg SJ, et al.: Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 1994, 90:127-138. (Pubitemid 24203672)
18. Baer FM, Voth E, Theissen P, et al.: Coronary artery disease: findings with GRE MR imaging and Tc-99mmethoxyisobutyl-isonitrile SPECT during simultaneous dobutamine stress. Radiology 1994, 193:203-209.
19. Nagel E, Lehmkuhl HB, Bocksch W, et al.: Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999, 99:763-770. (Pubitemid 29083016)
20. Hundley WG, Morgan TM, Neagle CM, et al.: Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002, 106:2328-2333. (Pubitemid 35244733)
21. Paetsch I, Jahnke C, Ferrari VA, et al.: Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J 2006, 27:1459-1464. (Pubitemid 43998080)
22. Jahnke C, Paetsch I, Gebker R, et al.: Accelerated 4D dobutamine stress MR imaging with k-t BLAST: feasibility and diagnostic performance. Radiology 2006, 24:718-728. (Pubitemid 46190537)
23. Rerkpattanapipat P, Gandhi SK, Darty SN, et al.: Feasibility to detect severe coronary artery stenoses with upright treadmill exercise magnetic resonance imaging. Am J Cardiol 2003, 92:603-636.
24. Wahl A, Paetsch I, Roethemeyer S, et al.: High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. Radiology 2004, 233:210-216. (Pubitemid 39280976)
25. Lee DC, Simonetti OP, Harris KR, et al.: Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation 2004, 110:58-65. (Pubitemid 38880134)
26. Schwitter J, Nanz D, Kneifel S, et al.: Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001, 103:2230-2235. (Pubitemid 32433710)
27. Rieber J, Huber A, Erhard I, et al.: Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J 2006, 27:1465-1471. (Pubitemid 43998081)
28. Kühl HP, Katoh M, Buhr C, et al.: Comparison of magnetic resonance perfusion imaging versus invasive fractional flow reserve for assessment of the hemodynamic significance of epicardial coronary artery stenosis. Am J Cardiol 2007, 99:1090-1095. (Pubitemid 46560463)
29. Costa MA, Shoemaker S, Futamatsu H, et al.: Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol 2007, 50:514-522. (Pubitemid 47126780)
30. Futamatsu H, Wilke N, Klassen C, et al.: Evaluation of cardiac magnetic resonance imaging parameters to detect anatomically and hemodynamically significant coronary artery disease. Am Heart J 2007, 154:298-305. (Pubitemid 47069133)
31. Dall'Armellina E, Morgan TM, Mandapaka S, et al.: Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. J Am Coll Cardiol 2008, 52:279-286. Recent study demonstrating DSMR's usefulness in prognostic stratification of patients with reduced left ventricular function. (Pubitemid 351957860)
32. Rerkpattanapipat P, Morgan TM, Neagle CM, et al.: Assessment of preoperative cardiac risk with magnetic resonance imaging. Am J Cardiol 2002, 90:416-419.
33. Ingkanisorn WP, Kwong RY, Bohme NS, et al.: Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006, 47:1427-1432.
34. Jahnke C, Nagel E, Gebker R, et al.: Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007, 115:1769-1776. Study demonstrating the usefulness of stress MR for risk stratification in patients with known and suspected CAD, and direct comparison between DSMR and MR-PERF using a combined protocol. (Pubitemid 46648614)